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NF-kB: Ten Years After Meeting Review
Patrick A. Baeuerle* and David Baltimore† do not readily transform cells upon transfection. An ex-
ception is v-Rel which, however, can acutely transform*Tularik Inc.
only avian cells in culture. The transforming potentialTwo Corporate Drive
of a RelA splice variant called p65D in rodent cells re-South San Francisco, California 94080 CA 94080
mains a matter of debate (Narajanan et al., 1992; GrimmDepartment of Biology
and Baeuerle, 1994). T. Gilmore (Boston University, Bos-†Massachusetts Institute of Technology
ton) reviewed the properties of v-Rel that contribute to77 Massachusetts Ave.
its transforming potential. Weak transactivating poten-Cambridge, Massachusetts 02139–4307
tial, DNA binding, and homodimer formation are required
whereas interaction with IkB is not critical. In an effort to
understand its mechanism of transformation, two v-Rel-Almost exactly ten years following the first publication
interacting proteins were cloned by yeast two hybridon NF-kB (Sen and Baltimore, 1986), researchers work-
screening and shown to have transactivating potentialing on transcriptional regulation by NF-kB/Rel and IkB
in yeast.proteins gathered for the third time to discuss recent
Strong evidence that NF-kB/Rel proteins can bedevelopments in the field (Madrid, July 8-10, 1996). The
proto-oncogenes inmammals came from studies in Bra-
first meeting of its kind was a Howard Hughes workshop
vo’s laboratory. v-Rel expressed in transgenic mice un-
at the NIH in November 1992 and the second one a
der T cell-specific control (lck proximal promoter)
Banbury Conference held at Cold Spring Harbor in Octo-
caused early death of animals from multicentric aggres-
ber 1993. This year’s meeting was organized by R. Bravo
sive T cell lymphomas. A similarly expressed C-termi-
(Bristol-Myers Squibb, Princeton) and P. S. Lazo (Uni-
nally truncated c-Rel did not have this affect, indicating
versidad de Oviedo) and held at the Juan March Founda- that v-Rel is not oncogenic simply because it lacks most
tion in Madrid, Spain. of the C-terminal transactivation domain of its cellular
NF-kB is the prototype of a family of dimeric transcrip- counterpart c-Rel. The v-Rel-transformed murine T cells
tion factors (Figure 1) made from monomers that have were of immature phenotype and dependent on IL-2. In
approximately 300 amino-acid Rel regions which bind these cells, v-Rel was predominantly associated with
to DNA, interact with each other, and bind the IkB inhibi- p50 and partially with IkB-a. The prevalence of constitu-
tors (for most recent reviews, see Verma et al., 1995; tively active v-Rel/p50 may explain the upregulation of
Baldwin, 1996). The inhibitors all have 5–7 ankyrin (Ank)
repeat domains, each about 30 amino acids, which form
a unit able to interact with Rel regions. Even before
the meeting, it was evident that the importance of Rel-
related transcription factors is continuing to grow, as
reflected by the ever-increasing number of publications
in the field (now, more than 1,200 in total) and the never-
ending revelations from a large number of effective labo-
ratories. By the end of the meeting, the participants
appreciated that this transcription factor system still is
a hot discovery zone and far from having reached a
state of clean-up experimentation.
The high level of interest in Rel-based transcription
factors is founded on their broad role in inducibly and
coordinately controlling genes of significant biomedical
importance, such as those encoding inflammatory cyto-
kines, chemokines, interferons, MHC proteins, growth
factors, cell adhesion molecules, and viruses (reviewed
by Baeuerle and Henkel, 1995). The workshop mainly
concentrated on understanding the functional roles of
NF-kB and IkB proteins in immune regulation and devel-
opment, using knock-out and transgenic animals mod-
els, and on deciphering the specificities and molecular
control mechanisms by which the multiple DNA binding
and inhibitory subunits that make up the Rel/Ank family
of proteins interact with each other in various cell types.
NF-kB/Rel in Malignant Transformation Figure 1. The NF-kB/IkB Paradigm
and Hyperplasia
All currently known members of the NF-kB/Rel family (shown in
Some of the Rel proteins, notably c-Rel, were first identi- yellow and green) and IkB family (red), and a selection of important
fied by their involvement in abnormal growth of B and functions of the transcription factor system are listed. Dorsal, Dif,
Relish, and Cactus are from Drosophila.T cells (reviewed by Gilmore et al., 1996). However, they
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NF-kB target genes such as IL-6 and ICAM-1. Crossing These various results all suggest that pro-apoptotic
extracellular signals can also induce NF-kB which inthe v-Rel transgenic mice with mice overexpressing
IkB-a under lck control caused a delay in death from turn probably induces expression of genes that are anti-
apoptotic. Viruses that can induce NF-kB could there-leukemia. In mice with a disrupted p105/p50 gene, T
cell leukemia appeared at an earlier stage, suggesting fore protect against apoptotic elimination of infected
cells.that v-Rel homodimer formation (due to a lack of the
alternative p50 heterodimerization partner) may be the There is some evidence, albeit less direct, of a pro-
apoptotic aspect of RelA activity. Grimm et al. (1996)key issue in transforming potential, as observed in
the chicken system. recently showed that serum starvation of 293 cells
causes cell death accompanied by the activation ofAberrant p52 proteins are found in T cell lymphomas,
as a result of chromosomerearrangements at theNFKB2 RelA-containing NF-kB. Bcl-2 or a dominant negative
RelA mutant could prevent both cell death and kB-locus (Neri et al., 1991 ). p52 is normally produced as
p100, an inactive precursor harbouring IkB-like Ank- dependent reporter gene activation. A pro-apoptotic
role of NF-kB/Rel was also suggested by the study ofcontaining sequences in its C-terminal half. R. Bravo
reported on transgenic mice in which the C-terminal radiation-sensitive fibroblasts from ataxia telangiectasia
(AT) patients (A. Dritschilo, Georgetown University,portion of p100 is disrupted leading to production of
constitutive p52. The phenotype is neonatal lethality, Washington D. C.). Radiation-induced cell apoptosis in
AT cells was reduced by a dominant negative IkB-aapparently because of reduced food intake. The reason
appears to be hyperplasia of the stomach lining. There protein (Jung et al., 1995). Perhaps RelA can control
apoptosis in quite opposite manners depending on bothwas no abnormality of B or T cell development but their
T cell response was increased while macrophage activi- cell type and the nature of the apoptotic stimulus.
c-Rel may also play a role in inducing apoptosis, asties were reduced. Increased constitutive NF-kB activity
was detectable in several organs by anti-p52 antibodies. was earlier suggested by Abbadie et al. (1993). C. Geli-
nas (UMDNJ, Piscataway) observed apoptosis upon ex-These data suggest a role of p52 in epithelial growth
control. R. Bravo also mentioned a partial disruption of pression of c-Rel in a HeLa cell line stably expressing
the c-Rel gene under inducible control by the tet repres-p105 that inactivates its C-terminal portion and would
lead to the expression of constitutive p50; such mice sor. c-Rel-induced apoptosis involved cell cycle arrest
at G1/S correlating with inhibition of E2F DNA bindingwere apparently healthier than IkB-d knockouts.
activity, accumulation of hypophosphorylated Rb, inhi-
bition of Cdk2 kinase, and accumulation of transcriptsNF-kB/Rel in the Control of Apoptosis
A major cause of embryonic death of mice lacking the encoding the Cdk inhibitor p21Waf1. It will be interesting
to investigate whether the kB motifs in the p21 promoterRelA subunit is a massive apoptosis of liver cells (Beg
et al., 1995), suggesting a role for RelA-containing NF- are functional and can bind c-Rel. It remains tobe under-
stood how RelA can protect from apoptosis while itskB dimers in protecting cells from pro-apoptotic stimuli
produced in the embryonic liver, perhaps by resident potential dimerization partner c-Rel induces apoptosis.
One explanation could be that the kB motifs in pro- andhaematopoetic cells. Data from several presentations
supported this notion by showing that the absence or anti-apoptotic genes selectively bind complexes with
c-Rel or RelA, respectively. It is also conceivable thatinhibition of NF-kB/Rel in cultured cells potentiated
apoptosis in response to TNF or T cell activation. D. overexpression of c-Rel prevents formation of RelA di-
mer combinations that are required for inducing anti-Baltimore (MIT, Cambridge) showed that the RelA sub-
unit played such a role in macrophages and a fibroblast apoptotic genes.
In contrast to c-Rel, its retroviral counterpart v-Relline established from RelA2/2 mice. Compared to wild
type cells, TNF readily killed these cells through TNF does not induce cell death. On the contrary, C. Gelinas
observed in a tetracycline-dependent system thatreceptor type 1 and could be prevented by transfected
RelA. A similar phenotype was observed by I. M. Verma downregulation of v-Rel causes apoptosis in chicken
spleen cells, consistent with results obtained by T. Gil-(Salk Institute, La Jolla) and D. W. Ballard (Vanderbilt
University, Memphis) using cell lines stably transfected more using a temperature sensitive v-Rel mutant.
with dominant negative IkB-a proteins produced, re-
spectively, by point mutants in all known phosphoryla- NF-kB/Rel in Immune Functions
To study the impact of the RelA null mutation on thetion sites or deletionof the regulatory N-terminus. Stable
expression of such IkB mutants would correspond to a developmentof the immune system,hematopoietic cells
from fetal livers of RelA2/2 mice were transferred intoknockout of all five NF-kB/Rel subunits as evident from
the complete absence of any kB-specific DNA binding lethally irradiated mice (D. Baltimore). The recipient mice
survived and developed a functional immune system. Tactivity in extracts from cell lines stimulated with cyto-
kines. Although the contribution of a particular subunit and B cellsas well as macrophages appeared todevelop
normally and showed unaltered responses. However,cannot easily be deciphered by this approach, the phe-
notype of cells with respect to apoptotic resistance was an increase in granulocytes in peripheral blood and the
bone marrow was apparent that developed into an in-very similar to that of RelA2/2 cells. When a dominant
negative IkB mutant was expressed in transgenic mice flammation of distal extremities, such as swelling of
paws, suggesting a negative control function of RelA inunder control of theT cell-specific lck promoter, a loss of
CD81 cells was observed in the thymus (D. W. Ballard). granulopoiesis.
Among all the single knockouts of NF-kB/Rel sub-Moreover, the activation-induced apoptosis of T cells
derived from the transgenic mice was enhanced. units, c-Rel2/2 mice showed a phenotype that is most
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consistent with the notion that the transcription factor other k enhancer, 39 to the coding region, is unrespon-
sive to LPS). No effect on RAG-1 and -2 levels wasplays a key role in cytokine regulation and proper im-
mune cell responses. S. Gerondakis (Walter and Eliza evident. Either the cell lines show a different depen-
dence on NF-kB than do cells in intact mice, or whenHall Institute, Victoria) reviewed the properties of c-
Rel2/2 mice (Koentgen et al., 1995). These fail to mount multiple Rel proteins are eliminated the results on B cell
development will be different from those with singlean effective humoral and cellular immune response to
variouspathogens, including Leishmania major.Prolifer- knockouts.
To study the effect of the IkB-a dominant mutant ination defects as well as decreased production of cyto-
kines and immunoglobulins were seen in T and B cells, T cells, the protein was expressed under control of the
proximal lck promoter in the thymus of transgenic mice.respectively. His studies of macrophages revealed a
difference between the properties of resident cells, Thymocytes had most of their NF-kB/Rel proteins com-
plexed to and inactivated by the signal-resistant IkBwhich killed bacteria poorly, and those elicited by thio-
glycollate, which showed normal killing. The resident mutant. As a consequence, there were fewer peripheral
T cells and their proliferative response to a variety of Tmacrophages showed diminished NO production, which
correlated with reduced LPS-inducible iNOS expres- cell-activating conditions was totally blocked and could
not be restored by exogenous IL-2. This provided goodsion. While TNF-a production in response to LPS was
also reduced, the expression of GM-CSF, G-CSF, and evidence that the NF-kB/Rel signaling pathway is as
important as theNFAT/AP-1 pathway in T cell activation.IL-6, three other NF-kB/Rel-regulated genes, was ele-
vated. The animals were more susceptible to influenza A potentially important aspect of NF-kB function
emerged from the study of demethylation of the Igkvirus and Leishmania than wild type animals.
RelB knockout mice are characterized by multiorgan locus in a construct dependent on the intronic k en-
hancer (T. Wirth, ZMBH, Heidelberg). In the S107 my-inflammation due to infiltration of mixed inflammatory
cells accompanied by myeloid hyperplasia and spleno- eloma cell line, there is no nuclear content of Rel-related
proteins and no demethylation of this Igk construct.megaly (Weih et al., 1995). R. Bravo reported that T cells
were involved because crossing the RelB knockoutmice However, demethylation could be restored upon trans-
fection of a RelB expression vector that puts the RelBwith mice deficient in B and T cells (RAG-1 knockout)
or T cells alone (Nur77/N10TG knockout) suppressed protein into the nucleus. This suggests that the intronic
enhancer can mediate demethylation but, as seen fortheir RelB2/2 phenotype. A RelB/p105 double knockout
showed an increased mortality due to a more penetrant transcription and rearrangement, only if its kB site is
occupied by a Rel protein.phenotype despite the absence of B cells in infiltrates.
RelB2/2 mice could not clear infections with Listeria mo-
nocytogenes or lymphocytic choriomeningitis virus. Se- NF-kB/Rel in Embryonic Development
rum IgM and IgE levels were elevated while antigen- None of the null mutants for the five known murine Rel
specific IgG production was down, indicating impaired subunits showed a detectable defect in embryonic de-
T helper cell function. velopment. The same was true for the few double knock-
NFKB1 knockout mice, unable to produce p105 or its outs produced to date. It was thus surprising to learn
cleavage product p50, show multiple defects in B cell from the presentation of L. D. Kerr (Vanderbilt University,
function (Sha et al., 1995). J. Caamano from Bravo’s Memphis) that c-Rel appeared tobe important for proper
laboratory reported on a knockout of NFKB2, the gene limb bud development in mice. Using a c-Rel promoter-
that produces p100 and its cleavage product p52. Like driven LacZ gene, high transgene expression was seen
the NFKB1 knockout mice, these develop normally. in the developing limb bud, correlating with elevated
However, again like the animals lacking p50, these mice c-Rel transcript levels. Normal murine limb bud develop-
have a serious defect in the B cell lineage. They have ment was impaired if a recombinant Adenovirus ex-
fewer B cells and even fewer mature B cells, a problem pressing a transdominant negative IkB-a gene was in-
that becomes more severe as the mice age. The spleen jected (it is relevant to note that all Rel proteins would
and lymph nodes have diffuse B cell areas with no folli- have their action blocked in this way, not just c-Rel).
cles or germinal centers. B cell proliferation was signifi- Evidence was presented that in embryos FGF-4 could
cantly impaired in response to LPS, anti-d-dextran, or induce c-Rel, which may regulate the expression of the
CD40 ligand. The phenotype of p100/p522/2 mice was homeodomain protein Msx-1. The Msx-1 promoter con-
similar to that of a Bcl-3 knockout (see below), support- tains functional kB motifs that may be required for acti-
ing a functional relationship between the two proteins.
vation of the gene through c-Rel in response to morpho-
None of the individual knockouts showed a defect in
gens. A. Israel (Pasteur Institute, Paris) pointed out that
B cell development but experiments in preB cell lines
no limb bud staining was evident in transgenic mice
with an overexpressed dominant negative IkB-a—able
where the LacZ gene is driven by three kB sites. A c-Rel/
to prevent the presence of all nuclear Rel proteins—
RelA/RelB tripple knockout may be the best means to
gave a different answer (D. W. Ballard). Transcription
investigate a role of kB-dependent gene activation in
and rearrangement of the germ line Igk genes induced
early vertebrate development.
in these cells by LPS was entirely abrogated by the
IkB. The same dominant IkB-mediated suppression was
Role of Bcl-3found in a temperature-sensitive Abelson virus trans-
Bcl-3 is an unusual IkB protein in that it can not onlyformant which ordinarily is induced to transcribe and
inhibit nuclear NF-kB complexes but can bind to p50rearrange k by temperature shift. These results point to
a key role for the kB site in the intronic k enhancer (the and p52 dimers on DNA and provide the complexes with
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Figure 2. Regulatory Phosphorylation Sites
in Four IkB Proteins
Phosphorylated serine residues are circled.
A consensus sequence for both sites of
DXXXXS is proposed. All sites are located in
the N-terminal regulatory domain of the IkB
proteins.
transactivating activity (Bours et al., 1993; Fujita et al., (reviewed by Baeuerle and Henkel, 1995). Hence it is
not too surprising that, during evolution, a large virus1993). Its highest expression is found in lymph nodes
and spleen. Mice deficient for Bcl-3 showed normal de- acquired an IkB-like protein which could attenuate the
cell’s antiviral response, although the virus might thenvelopment and seemed healthy until challenged with
either Toxoplasma gondii (U. Siebenlist, NIH, Bethesda) have to worry about the cell’s apoptotic response. Such
a viral IkB-like protein was found in the African Swineor Staphylococcus pneumonia (I.M. Verma). In contrast
to wild type mice, the null mutants could not clear these Fever Virus, a pathogen receiving particular attention in
Spain perhaps because of the dietary importance ofpathogens and rapidly succumbed to the infections. U.
Siebenlist reported that, while many immunological pa- marvelous sausages and air-dried ham from pork (M.
Fresno, Universidad Autonoma de Madrid). The largerameters of B and T cells seem normal, less cells could
be extracted from Bcl-32/2 lymph nodes, which lacked DNA virus encodes a 28.2 kDa multiple Ank domain-
containing polypeptide (A238L) with functional charac-germinal centers and B cell follicles. Apart from these
histologically-apparent deficiencies, TH2 cells from null teristics of a bona fide IkB protein. In virus-infected
cells, A238L was found associated with NF-kB, and cellsmutants could not produce significant amounts of
g-interferon. This explained the reduced NO production become deficient for NF-kB activation in response to
TNF.in macrophages and a decreased CTL activity, showing
that Bcl-3 plays a critical role in antigen-specific T cell Until recently only two NF-kB/Rel proteins, Dif and
Dorsal, and one IkB family member, Cactus, were knownimmunity.
to occur in insects. This number is now increased in
both families through the discovery of a novel p100/New Members of the NF-kB and IkB
p105-like protein, amusingly called Relish, with both aFamilies and Interacting Proteins
Rel homology domain and an Ank repeat domain (D.S. Whiteside and A. Israel (Pasteur Institute, Paris) re-
Hultmark, Stockholm University). Relish was identifiedported on the characterization of IkB-e, a novel protein
as a gene that was highly upregulated upon bacterialwith six ankyrin repeats belonging to the IkB family. Its
infection of Drosophila. It is also expressed in early em-cDNA was isolated through a yeast two-hybrid screen
bryos, suggesting a possible role in embryogenesis aswith p52 as bait. By using two different start codons, in
well, and is now awaiting further biochemical and func-principle it can be translated into 38 and 55 kDa species
tional characterization.with N-terminal domains of different length. IkB-e shares
Screening of a l expression library with p52 as probemany properties with IkB-a: its 2.2 kB transcript is
led to the re-isolation of a kB-specific DNA-binding pro-induced by phorbol esters; it is a potent inhibitor of kB-
tein, called RkB (C. Scheidereit, MDC, Berlin), originallydependent gene expression; the constitutively phos-
isolated by G. Nabel and colleagues by screening aphorylated protein undergoes signal-induced hyperpho-
library with a DNA probe containing the IL2 receptorsphorylation and subsequent degradation which is
a-chain kB site (Adams et al., 1991). Despite its similarblocked by proteasome inhibitors and antioxidants; and,
DNA binding specificity, RkB is structurally completelylastly, its N-terminus harbors potential phosphorylation
unrelated to NF-kB/Rel proteins. C. Scheidereit showedsites similar to those in IkB-a (see Figure 2). In collabora-
that RkB has a C-terminal inhibitory domain, cannottion with N. Rice (NCI, Frederick), IkB-e was found to
bind IkB proteins but selectively associates with p50,be a major IkB protein associated with RelA in all cell
p52, and c-Rel, presumably via a coiled-coil region.lines investigated. In THP-1 macrophages, it even con-
stituted more than 90% of the IkB proteins. A major
difference from IkB-a and b was that IkB-e was exclu-
Control of IkB Activity by Kinasessively found in association with RelA and c-Rel. Provided
The central paradigm of NF-kB activation, which in-there are stimuli that selectively degrade or spare IkB-e,
volves the removal of IkB proteins from a cytoplasmica selective regulation of a certain NF-kB–Rel dimer com-
complex with NF-kB (Baeuerle and Baltimore, 1988a;bination (c-Rel–RelA and respective homodimers) would
1988b) (Figure 1), has now been subjected to very de-be possible.
tailed molecular analyses. The major pathway used byNF-kB plays an important role in the antiviral response
a variety of stimuli to activate NF-kB involves the phos-as a virus-inducible transcriptional regulator of b-inter-
feron, MHC class I, and inflammatory cytokine genes phorylation of IkB-a at its regulatory N-terminus on
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serines 32 and 36, an event leading to subsequent conju- in inflammatory cytokine signaling because the activa-
tion of an NF-kB reporter gene by TNF was impairedgation with ubiquitin and proteasome-mediated degra-
dation of the inhibitor (reviewed in Verma et al., 1996). by transdominant negative forms of Cdc42 and RhoA
though not Rac1.It is now evident that IkB-a (reviewed by Verma et al.,
1995), the novel IkB-e (S. Whiteside), and the Drosophila A number of studies have shown that IkB-a is constitu-
tively phosphorylated in its C-terminal PEST domain byIkB homologue Cactus (S. Wasserman, Southwestern
Medical Center, Dallas) all undergo a phosphorylation- casein kinase II. S. Wasserman showed that Cactus
also undergoes this modification and he purified andinduced proteolytic degradation in response to extracel-
lular stimuli. As shown in Figure 2, the regulatory phos- identified the responsible kinase as the Drosophila ca-
sein kinase II homologue. The role of the C-terminalphorylation sites in these four IkB proteins show a high
degree of similarity, suggesting that related kinases may domain of IkB proteins and its phosphorylation in con-
trolling protein turnover and association with Rel pro-modify the inhibitors in response to stimulation of cells.
Mutational analyses showed earlier that both sites in teins was a matter of dispute (I. M. Verma and N. Rice).
C. Scheidereit reported that the inducible degradationIkB-a need to be phosphorylated for efficient degrada-
tion. An IkB kinase that modifies both sites has not been and basal turnover of IkB-a are distinctly regulated. The
basal turnover of the protein appeared to be indepen-characterized in detail yet. A recent study by Chen et
al. (1996) described such a kinase as being part of a dent of ubiquitin conjugation, since no modification by
tagged ubiquitin was detectable and the mutation of alllarge 700 kDa complex and requiring polyubiquitination
for activity. A similarly sized complex was described by potential lysine acceptor sites to arginines did not alter
the half life of IkB-a. In contrast with the inducible break-F. Mercurio (Signal Pharmaceutics, San Diego), while
D. Baltimore found a 300 kDa kinase complex with an down, N- and C-terminal domains of IkB-a were dis-
pensable, leaving the Ank repeat domain as the majoractivity for the serines in the N-terminal region of IkB-a
that was not evident if they were replaced by threonine determinant of IkB-a’s normal half life. An involvement
of the proteasome for basal turnover was evident fromresidues. In the two latter cases, no requirement of the
kinase for ubiquitin was evident. the inhibitory effect of the peptide inhibitor ALLN.
W. C. Greene (Gladstone Institute, San Francisco)
showed that the mitogen-activated kinase pp90rsk can Novel Stimuli and Mechanisms Inactivating IkB
A number of nonclassical pathways of IkB inactivationphosphorylate IkB-a on serine 32 (but not serine 36) and
is able to physically associate with IkB-a in intact cells. were reported at the workshop that do not involve
N-terminal serine phosphorylation. In one case, stoi-Other IkB proteins were not modified by pp90rsk. This
finding could explain why transient overexpression of chiometric phosphorylation of IkB-a on tyrosine 42 was
observed in response to pervanadate treatment of Tkinases upstream of pp90rsk, such as MAPK, MEKK-1,
and MEKK-3, cause IkB-a degradation and NF-kB acti- cells or reoxygenation of hypoxic HeLa cells (J.-F.
Peyron, INSERM, Nice). In contrast toserine phosphory-vation (U. Siebenlist). The observation that pp90rsk is
activated by PMA, okadaic acid, and LPS but not by lation, this modification did not cause a subsequent
proteolytic degradation of the inhibitor but, apparently,TNF or HTLV-I Tax suggests that this kinase may be
predominantly used by mitogenic signaling pathways. was sufficient to release IkB-a from NF-kB and to po-
tently activate NF-kB. Future studies need to addressIt remained an open question how serine 36 would be
phosphorylated in such a scenario but such a phosphor- whether the release of tyrosine-phosphorylated IkB-a
requires the assistance of an SH2 domain-containingylation is apparently necessary for efficient degradation
of IkB-a. An attractive idea is that the synergistic effect protein. It will also be of great interest to see which
of the over one hundred conditions known to date tobetween calcium- and protein kinase C (PKC)/Ras/Raf-
dependent pathways in NF-kB activation observed in T activate NF-kB rely on tyrosine phosphorylation. Good
candidates are those activating tyrosine kinases, suchcells may have its molecular basis in the action of two
distinct kinases on IkB-a. Data from U. Siebenlist as PDGF, insulin, UV, H2O2, and IL-2.
T. Gilmore reported that induction of apoptosis byshowed that a constitutive Raf kinase could potently
activate NF-kB only in combination with a constitutive inactivation of the temperature sensitive v-Rel mutant
G37E in chicken B cells caused an N-terminal truncationform of calcineurin. Future studies will be needed to
examine whether the contribution from the PKC/Ras/ of pp40 (chicken IkB-a). This IkB processing can be
prevented by the viral protease inhibitor CrmA in intactRaf kinase pathway is via serine 32 phosphorylation by
pp90rsk whereas the calcium/calcineurin pathway leads cells and can be catalyzed in vitro by the ICE-like prote-
ase CPP32, suggesting that IkB can be a target forto phosphorylation on serine 36.
Small Ras-like GTPases belonging to the Rho family apoptosis-induced proteases. With another ts v-Rel mu-
tant (R273H), a complete degradation of pp40 was ob-are known regulators of protein kinases, such as JNK/
SAPKs and PAK, and other enzymes including phospho- served during apoptosis. The latter is consistent with a
persistent IkB-a depletion (and NF-kB activation) in 293lipases and phosphotidylinositol kinases. R. Perona (In-
stituto de Investigaciones Biomedicas, Madrid) showed cells that are induced to undergo apoptosis by serum
starvation (Grimm et al., 1996).that three members of the Rho family, RhoA, Cdc42,
and Rac1, potently activated NF-kB upon transient NF-kB is activated upon increasing the osmolarity of
the cell culture medium by sorbitol (A. Israel). This find-transfection in various cell types. The induction by the
Rho proteins selectively depleted IkB-a and was not ing may be of physiological relevance since there is a
high level of constitutive kB-dependent LacZ reporter-affected by trans-dominant negative mutants of Ras and
Raf. The Rho GTPases seemed to play an important role gene activity detectable in kidneys of transgenic mice.
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The NF-kB system may be employed in this organ as preventing stabilization of IkB-a in complex by NF-kB.
Through selective degradation of IkB-a and simultane-hyperosmolarity sensor and inducer of genes controlling
proper kidney function under these stress conditions. ous dephosphorylation of -b, a prolonged NF-kB activa-
tion could be achieved in which the rapidly resynthe-Again, protection from apoptosis comes to mind. While
in Jurkat and K562 cells, sorbitol induced IkB inactiva- sized IkB-a is largely ineffective. This may happen when
cells are stimulated with LPS (Thompson et al., 1995).tion by the classical pathway, the inactivation of IkB-a
in 70Z/3 pre-B cellswas independent of phosphorylation A prerequisite would be a kinase modifying IkB-a but
not -b in its N-terminus, like that described at the meet-of serines 32 and 36 and ubiquitin conjugation to lysines
20 and 21. Strong support for a novel pathway of NF- ing by D. Baltimore.
T. Wirth observed that IkB-b more strongly inhibitedkB activation camefrom the analysis of the 70Z/3mutant
line 1.3E2. This line was deficient for NF-kB activation p50–RelA than p50–RelB or p50–c-Rel complexes,
whereas IkB-a had a similar inhibitory activity towardin respone to LPS, PMA, and double-stranded RNA but
could still activate NF-kB in response to sorbitol and all three complexes. In pre-B cells cultured in the pres-
ence of IL-7, withdrawal of the cytokine initiated B cellthe phosphatase inhibitors calyculin A and okadaic acid.
Overloading the endoplasmic reticulum (ER) with differentiation accompanied by a selective degradation
of IkB-b and subsequent activation of NF-kB. Togethermembrane proteins, as would occur upon viral infection
or in genetic diseases such as cystic fibrosis, is another these studies provided evidence for both a differential
control of IkB activities and a differential regulation ofnovel stimulus activating NF-kB (Pahl et al., 1996). Phar-
macological evidence was presented to suggest that distinct NF-kB/Rel complexes by various IkB protein
members. The phenotypes of IkB-a and -b knockoutthe release of calcium from the organelle in response
to overload is required to trigger NF-kB activation (P. A. mice may therefore be rather distinct.
Baeuerle, Tularik Inc., South San Francisco). Intracellu-
larly activated calcium chelators prevented NF-kB acti- NF-kB Structure and Transcriptional Modulation
vation by ER overload (and okadaic acid) but not by P. B. Sigler (Yale University, New Haven) reviewed the
TNF. Moreover, two inhibitors of the ER-resident Ca21- structural features of the p50 dimer–DNA complex
ATPase, thapsigargin and cyclopiazonic acid, were (Ghosh et al., 1995 ; Mueller et al., 1995). He pointed
strong NF-kB-activating stimuli. The precise mechanism out that a total of 10 loops contribute to protein–DNA
of IkB inactivation by such stimuli remains to be eluci- recognition. Mutational analysis indicated that loop 1,
dated. in addition to more distant determinants, is involved in
interaction with IkB-a. This may provide a structural
NF-kB/Rel Regulation by IkB-b basis for understanding why binding of IkB and DNA to
IkB-b was described first in 1990 (Zabel and Baeuerle, p50 are mutually exclusive. Loop 1 would have to be
1990) and cloned in 1995 (Thompson et al., 1995). Bio- released from DNA to allow interaction with IkB. The
chemical work noted early on that the purified protein potential for asymmetry and plasticity of DNA binding
lost its inhibitory activity upon treatment with phospha- specificity at the dimer interface and minor groove was
tase (Link et al., 1992), suggesting it occurred in a basally emphasized.
phosphorylated form and required the modification for Based on mutational studies, it was previously postu-
inhibiting NF-kB. Studies by S. Ghosh (Yale University, lated that IkB-a directly binds the basic nuclear location
New Haven) and A. Israel showed that newly synthesized signal (NLS) sequence (Beg et al., 1992). N. Rice pre-
IkB-b migrates faster in SDS gels than the pre-existing sented NLS mutants of RelA that could still avidly bind
protein and is non- or hypophosphorylated. S. Ghosh to IkB-a (see also Kaltschmidt et al., 1995), consistent
compared the properties of nonphosphorylated bacte- with an indirect steric hindrance imposed by IkB to the
rial IkB-b with those of basally phosphorylated IkB-b. RelA NLS.
Both forms could associate with NF-kB but only the H. Cai (from Michael Levine’s laboratory now at UC
basally phosphorylated form prevented DNA binding. Berkeley) provided the only functional analysis of how
The complex of NF-kB with nonphosphorylated IkB-b Rel family proteins modulate transcription. Although
not only could bind to DNA but also had the nuclear most assays of vertebrate Rel proteins demonstrate
location signal sequence on RelA exposed, suggesting their activating capacity, she discussed the powerful
it may gain access to the nucleusand retain its transcrip- silencing role of Drosophila Dorsal. This requires quite
tional activity. A major purpose of the interaction of NF- specific DNA architecture, but in the zen gene, there are
kB with non- or underphosporylated IkB-b appears to
sites for Dorsal whose occupancy leads to silencing of
be to prevent newly-synthesized IkB-a from binding to
zen or reporter gene transcription in a distance- and
and re-inactivating NF-kB. In fact, NF-kB decorated with
orientation-independent manner.
IkB-b is far more resistant to IkB-a inhibition than is
normal NF-kB. This may be one molecular basis for a
Future Directionsprolonged or constitutive activation of NF-kB in a num-
The NF-kB/IkB system is a transcription control systember of systems. For instance, in WEHI 231 B cells that
that is brought into play in many situations of cellularcontain constitutive NF-kB/Rel complexes in their nu-
and organismal challenge. We can appreciate how farclei, all IkB-b was found in the nonphosphorylated form.
we have to go before the system is fully understood ifAlthough, compared to pre-B cells, mRNA levels of IkB-a
we consider that the only detailed knowledge that wewere dramatically increased, protein levels were rather
have of the system is the structure of (p50)2 bound tolow. The increased IkB-a protein turnover can be ex-
plained by the occupation of NF-kB proteins with IkB-b DNA. With that auspicious beginning, the field now looks
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Table 1. Phenotypes of NF-kB/Rel/IkB Transgenic and Knockout Mice
Targeted Gene/Alteration Most Obvious Phenotype Reference/Presenter
p105/p50 knockout multiple deficiencies in B cell function Sha et al. (1995)
RelA knockout embryonic lethal, liver cell apoptosis, Beg et al. (1995), Baltimore
granulopoiesis
RelB knockout lethal, multiple organ inflammation Weih et al. (1995), Bravo
c-Rel knockout B and T cell deficiencies Kontgen et al. (1995),
Gerondakis
p100/p52 knockout altered lymph node architecture Bravo
IkB-a knockout lethal, atrophic spleen and thymus, Beg et al. (1995)
granulopoiesis, skin defects
Bcl-3 knockout altered lymph node architecture Siebenlist, Verma
IkB-d knockout lethal, gastric hyperplasia Bravo
(p50 overexpression)
IkB-g knockout less severe than IkB-d Bravo
(p52 overexpression)
IkB-a transdominant controlled deficient thymocyte activation, CD81 Ballard, Verma
by proximal lck promoter cell loss
(kB)3 LacZ — Israel
c-Rel promoter LacZ — Kerr
p100/p105 double knockout more severe than single knockouts Bravo
p105/RelB double knockout more severe than single knockouts Bravo
RelB/RAG-1 double knockout cured from multiorgan inflammation Bravo
RelB/Nur77/N10TG double knockout cured from multiorgan inflammation Bravo
to structural biologists to clarify the interaction of NF-kB Three important areas of ignorance were underscored
in the meeting. One is new: the role of NF-kB in shieldingwith IkB and the differences among the various related
components of the system. cells from apoptotic death. The role of the system in
regulating whether cells live or die now needs to beWhile we recognize that there are many signals that
lead to IkB removal from NF-kB, the pathways of signal- characterized in the various situations where apoptosis
occurs, such as in tissue modeling, T cell selection, anding remain to be elucidated. The greatest need is a
molecular definition of the kinase(s) that directly phos- response to noxious stimuli. The second takes us back
to the initial discovery of c-rel as a proto-oncogene: howphorylate IkB and lead to its degradation. There may
even be multiple kinase activities that can lead to activa- does activated c-Rel cause cellular transformation? The
key role of the v-Rel dimer acting as a transcriptionaltion including ones that phosphorylate tyrosines and
lead to dissociation of IkB rather than degradation. Once activator seems clear but the target genes remain to
be defined. Finally, the developmental role of NF-kBthe activation step is understood—and the definition of
the sites of phosphorylation represents major progress remains controversial. Protection against fetal hepato-
cyte apoptosis is one role but there may be many others.in that quest—then the challenge will be to fill in the
steps between the engagement of receptors, such as There is no suggestion that the elegant role of Dorsal
in establishing the dorsal-ventral axis of the Drosophilathose for TNF and IL-1, and the activation of the ki-
nase(s). embryo has a vertebrate counterpart and even the ho-
mology of the Tube-Pelle signaling pathway for DorsalWe do not know the key target genes of the various
NF-kB-related proteins in most situations except per- with any vertebrate system remains unclear.
Small, focused meetings of this kind allow the prog-haps in the T cell where the lack of proliferation in the
c-Rel knockout can be overcome with IL-2. The knock- ress in a limited area of science to be criticallyevaluated.
In the transcription field this is particularly valuable be-outs and transgenic animals (Table 1) have begun to
delineate the physiological roles of the individual sub- cause the multiplicity of related proteins, the many tar-
get genes, and the complex regulation of activity canunits but it seems likely that redundancy masks the
full importance of the system, requiring that mice with only be unraveled by integrating the efforts of many
laboratories. Other fields would benefit from such fo-multiple knockouts be bred to give a full picture. With
the discovery of yet another IkB protein, the need to cused meetings from which reports such as this can
convey progress to the rest of the community.understand the roles of the individual IkB’s is under-
scored. The key role of IkB-a in lymphoid cells and in
recovery of NF-kB from the nucleus following cessation Acknowledgments
of a signal was uncovered by theknockout and biochem-
We are grateful to Romunda Craft for help with preparing the manu-istry but the roles of -b and -e remain to be understood.
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and p52 precursors in controlling NF-kB activation is
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